Bond Screener
PDL BioPharma
LEI FE4K0NQFI4D86DSOL165
Organization name
PDL BioPharma, Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
-
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
PDL BioPharma (known as Protein Design Labs prior to 2006). PDL was founded in 1986 and is headquartered in Incline Village, Nevada. PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases for which it receives significant royalty revenue.
|
General information
-
Organization namePDL BioPharma, Inc.
-
Organization statusOperating organization
-
Address932, Southwood Boulevard Incline Village-Crystal Bay, USA, 89451
-
Site
IFRS/US GAAP reports
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show more
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization namePDL BioPharma, Inc.
-
Organization statusOperating organization
-
Address932, Southwood Boulevard Incline Village-Crystal Bay, USA, 89451
-
Site
Codes
-
LEIFE4K0NQFI4D86DSOL165
-
SIC2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
-
NACE*** ***
-
NAICS*** ***
-
CIK0000882104
